Prime Medicine, Inc. financial data

Symbol
PRME on Nasdaq
Location
60 First St., Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 515 % -7.57%
Debt-to-equity 167 % +281%
Return On Equity -164 % -42.2%
Return On Assets -61.2 % +23.4%
Operating Margin -3.41K % +87.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 181M shares +37.6%
Common Stock, Shares, Outstanding 180M shares +37.5%
Entity Public Float 297M USD -50.8%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 161M shares +34%
Weighted Average Number of Shares Outstanding, Diluted 161M shares +34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.98M USD +647%
Research and Development Expense 160M USD -1.61%
General and Administrative Expense 49.9M USD -2.03%
Operating Income (Loss) -204M USD +9.87%
Nonoperating Income (Expense) 6.63M USD -5.88%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -197M USD +9.99%
Earnings Per Share, Basic -1 USD/shares +30.1%
Earnings Per Share, Diluted -1 USD/shares +30.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71.4M USD -39.5%
Cash, Cash Equivalents, and Short-term Investments 213M USD +21.5%
Other Assets, Current 15.6M USD +63.8%
Assets, Current 231M USD -5.96%
Property, Plant and Equipment, Net 22M USD -5.33%
Operating Lease, Right-of-Use Asset 118M USD +139%
Other Assets, Noncurrent 0 USD -100%
Assets 385M USD +15.7%
Accounts Payable, Current 9.35M USD +72.3%
Employee-related Liabilities, Current 6.76M USD -10%
Accrued Liabilities, Current 11M USD -41.1%
Contract with Customer, Liability, Current 6.95M USD -25.1%
Liabilities, Current 35M USD -7.55%
Contract with Customer, Liability, Noncurrent 59.8M USD -4.61%
Deferred Income Tax Liabilities, Net 134K USD +74%
Operating Lease, Liability, Noncurrent 110M USD +200%
Liabilities 223M USD +55.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 33K USD +57.1%
Retained Earnings (Accumulated Deficit) -842M USD -30.6%
Stockholders' Equity Attributable to Parent 162M USD -14.6%
Liabilities and Equity 385M USD +15.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.9M USD +27.8%
Net Cash Provided by (Used in) Financing Activities 6M USD -96.2%
Net Cash Provided by (Used in) Investing Activities -47.7M USD -28.9%
Common Stock, Shares Authorized 775M shares 0%
Common Stock, Shares, Issued 180M shares +37.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -90.6M USD -272%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85.1M USD -35.6%
Deferred Tax Assets, Valuation Allowance 180M USD +50.8%
Deferred Tax Assets, Gross 193M USD +56.6%
Operating Lease, Liability 118M USD +186%
Payments to Acquire Property, Plant, and Equipment 2.42M USD +4.22%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -197M USD +9.93%
Lessee, Operating Lease, Liability, to be Paid 190M USD -8.82%
Property, Plant and Equipment, Gross 40.6M USD +15.5%
Operating Lease, Liability, Current 7.71M USD +72%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.4M USD -4.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 21.7M USD +9.76%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +86.7%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71.6M USD +137%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22.3M USD -2.74%
Deferred Tax Assets, Operating Loss Carryforwards 61.5M USD +70.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21.5M USD -3.66%
Additional Paid in Capital 1B USD +20.3%
Depreciation, Depletion and Amortization 7.16M USD +26.6%
Share-based Payment Arrangement, Expense 30.7M USD +25%